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During epithelial tissue morphogenesis, develop-
mental progenitor cells undergo dynamic adhesive
and cytoskeletal remodeling to trigger proliferation
and migration. Transcriptional mechanisms that
restrict such a mild form of epithelial plasticity
to maintain lineage-restricted differentiation in
committed epithelial tissues are poorly understood.
Here, we report that simultaneous ablation of tran-
scriptional repressor-encoding Ovol1 and Ovol2
results in expansion and blocked terminal differ-
entiation of embryonic epidermal progenitor cells.
Conversely, mice overexpressing Ovol2 in their skin
epithelia exhibit precocious differentiation accompa-
nied by smaller progenitor cell compartments. We
show that Ovol1/Ovol2-deficient epidermal cells fail
to undertake a-catenin-driven actin cytoskeletal
reorganization and adhesive maturation and exhibit
changes that resemble epithelial-to-mesenchymal
transition (EMT). Remarkably, these alterations and
defective terminal differentiation are reversed upon
depletion of EMT-promoting transcriptional factor
Zeb1. Collectively, our findings reveal Ovol-Zeb1-
a-catenin sequential repression and highlight Ovol1
and Ovol2 as gatekeepers of epithelial adhesion and
differentiation by inhibiting progenitor-like traits and
epithelial plasticity.
INTRODUCTION
A fundamental question in developmental biology is how epithe-
lial cells maintain dynamic yet stable intercellular adhesions
to support tissue morphogenesis (Maiden and Hardin, 2011).
Mammalian skin epithelia offer a prime model system to address
this. The epidermis and its associated appendages (e.g., hairDfollicle or HF) develop from a single-layered surface ectoderm
during embryogenesis (Koster et al., 2007). Following commit-
ment, epidermal basal cells either differentiate, delaminate, and
migrate up to become suprabasal cells, or divide asymmetrically
to produce a proliferative daughter cell that remains basal and a
transiently proliferative spinous cell that assumes a suprabasal
location (Fuchs, 2008). In upwardmovement, spinous cells differ-
entiate into granular keratinocytes, which go on to produce the
outermost stratum corneum constituting a vital permeability bar-
rier. Likewise, committed HF cells undergo expansion and first
downward then upward migration on their journey to produce a
hair shaft (Jamora andFuchs, 2002). Epidermal andHFstem/pro-
genitor cells face the challenging need of dampening intercellular
adhesions to promote proliferation andmigrationwhile achieving
stable cell-cell contacts upon tissue maturation (Fuchs, 2007).
Adherens junctions and their associated proteins such as E-cad-
herin (Ecad) and a-catenin lie at the heart of these dynamics
(Fuchs and Nowak, 2008). Consistently, ablation of Cdh1
(Ecad) or Ctnna1 (a-catenin) in the epidermis results in abnormal
intercellular adhesion, hyperproliferation, and altered differentia-
tion (Tinkle et al., 2004; Vasioukhin et al., 2000, 2001). The result-
ing defects are significantly more dramatic for the loss of a-cate-
nin, in keepingwith its central role in integrating cell adhesion and
actin cytoskeleton dynamics with growth signaling (Maiden and
Hardin, 2011). To date, transcriptional mechanisms regulating
adherens junction proteins have been largely focused on Ecad,
whereas the regulation of a-catenin has been thought to occur
through genetic mutations and/or posttranslational mechanisms
(Kobielak and Fuchs, 2004).
Interesting parallels exist between the afore-described devel-
opmental epithelial plasticity in skin and the process of epithelial-
to-mesenchymal transition (EMT) (Jamora and Fuchs, 2002;
Kalluri and Weinberg, 2009). During EMT, epithelial cells lose
cell-cell junctions and apical-basal polarity, reorganize their
cytoskeleton and shape, gain increased motility, and become
mesenchymal cell types. Central to promoting the EMT program
are transcription factors of the Snail, Twist, and Zeb families
(Thiery et al., 2009; Yang and Weinberg, 2008). Developing
skin epithelia express EMT-promoting factors: Snail is transiently
expressed in HF primordia, and Slug is expressed in embryonicevelopmental Cell 29, 47–58, April 14, 2014 ª2014 Elsevier Inc. 47
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2010). K14 promoter-directed overexpression of Snail results
in epidermal hyperproliferation and downregulation of Ecad
(Jamora et al., 2005), whereas Slug null mice show delayed HF
development and a thinner epidermis (Shirley et al., 2010).
Whether these EMT factors act by promoting physiological
adhesive and cytoskeletal remodeling during morphogenesis
remains to be demonstrated. More importantly, the molecular
mechanisms that restrict developmental epithelial plasticity
to ensure coordinated proliferation and differentiation of skin
epithelial progenitor cells are complete unknowns.
The Ovo family of zinc finger transcription factors constitutes
a downstream hub of signaling pathways, including Wg/Wnt,
epidermal growth factor (EGF), and bone morphogenetic protein
(BMP)/transforming growth factor b (TGF-b) (Descargues et al.,
2008; Gomis et al., 2006; Li et al., 2002b; Nair et al., 2006; Payre
et al., 1999; Zhang et al., 2013). Ovol1 null mice display epithe-
lial anomalies including mildly hyperproliferative epidermis,
abnormal hair shafts, defective spermatogenesis, and kidney
cysts (Dai et al., 1998; Li et al., 2005; Nair et al., 2006; Teng
et al., 2007), whereas Ovol2 null mice die during midgestation
(Mackay et al., 2006). In this work, we report studies that uncover
compensatory/redundant roles of Ovol1 and Ovol2 as negative
regulators of a progenitor cell state and positive regulators of
terminal differentiation in at least two skin epithelial lineages:
interfollicular epidermis and HFs. Moreover, we provide compel-
ling evidence that Ovol1/Ovol2 promote the differentiation of
epidermal progenitor cells in part by inhibiting EMT pathway
components such as Zeb1, which in turn represses Ctnna1
(a-catenin) transcription. These findings open the door to under-
standing the molecular control of developmental epithelial plas-
ticity and epidermal differentiation by studying the involvement
of other classical EMT regulators.
RESULTS
Simultaneous Ablation of Ovol1 and Ovol2 Results in
Defective Maturation of Embryonic Epidermis and HFs
In addition to Ovol1 (Li et al., 2002a; Nair et al., 2006), Ovol2 is
also expressed in epidermal and HF progenitor cells as they
mature during embryogenesis. Nuclear Ovol2 is present pre-
dominantly in basal but also a few suprabasal epidermal cells,
as well as in the down-growing front of developing HFs (Fig-
ure 1A). When epidermal cells were laser captured for RNA
analysis, a significant increase in Ovol2 mRNA was seen from
embryonic day 13.5 (E13.5) to E16.5 (Figure 1B). To investigate
Ovol2 function in skin, we generated skin epithelia-specific
Ovol2 knockout (SSKO: Ovol2f//K14-Cre) mice (Figure S1A
available online). These mice developed normally, with their
skin exhibiting no remarkable morphological or biochemical
defects (Figures S1B and S1C) but showing a dramatically
elevated level of Ovol1 mRNA, especially in basal keratinocytes
(Figures S1D and S1E). These findings, together with our previ-
ous observation of elevated Ovol2 expression in Ovol1-deficient
epidermis (Teng et al., 2007), raise the possibility of compensa-
tion/redundancy between Ovol1 and Ovol2.
To address this, we generated Ovol1/Ovol2 double-knockout
(DKO: Ovol1//Ovol2f//K14-Cre) mice. Like Ovol1/ (Nair
et al., 2006), DKO embryonic epidermis contained an expanded48 Developmental Cell 29, 47–58, April 14, 2014 ª2014 Elsevier Inc.K1-positive spinous compartment (Figures 1C and 1D).
Moreover, DKO epidermis displayed a number of features not
observed inOvol1/. First, K5/K14/K15-positive cells expanded
beyond the basal compartment, especially at earlier stages of
development (Figures 1E and 1F; data not shown). Second, cells
throughout the basal and spinous layers displayed abnormal
morphology and shape and were often separated by notable
intercellular spaces (Figures 1C and S1F). Third, the granules
and cornified layers appeared immature, defects most promi-
nently evident in electron microscopic (EM) and semithin images
(Figures 1G and S1F). Consistently, the levels of late differen-
tiation markers involucrin and filaggrin were decreased (Fig-
ure S1G). Finally, DKO epidermis failed to shed the K15-positive
peridermwhen stratification should be complete (Figures 1C and
1F). In keeping with these maturation defects, DKO embryos
lacked a functional permeability barrier, as illustrated by persis-
tent dyepenetration (Byrne et al., 1994)beyondE17.5 (Figure 1H).
HFs in DKO embryos also failed tomature properly. Compared
to counterparts in control and Ovol1/ skin, DKO HFs were
smaller (Figure 1I), and their length was decreased (Figure 1J).
Moreover, the number of HFs that express AE13, a hair ker-
atin marker of the differentiating precortex/cortex cells, was
decreased (Figure 1K). Collectively, our data reveal compensa-
tory/redundant roles of Ovol1 and Ovol2 in restricting the size of
the basal/spinous compartments and in facilitating terminal dif-
ferentiation within both interfollicular epidermal and HF lineages.
Loss of Ovol1/Ovol2 Leads to Increased Basal Cell
Proliferation and Expanded Progenitor Cell Marker
Expression
Next,weaskedwhether theexpandedbasal compartment inDKO
epidermis associates with increased proliferation, by quantifying
the number of phospho-histone H3 (pH3)-positive mitotic cells.
Compared to control and Ovol1/, DKO epidermis contained a
higher number of mitotic cells in the basal layer (Figure 2A). To
assess whether Ovol1/Ovol2 play a keratinocyte-autonomous
role in basal cell proliferation, we cultured primary keratinocytes
fromE18.5 DKO and control embryos in low-Ca2+medium,which
mimics the basal state. DKOkeratinocytes grewmore rapidly and
reached confluence faster than control and Ovol1/ cells (data
not shown). When plated at a clonal density, DKO and Ovol1/
keratinocytes produced a significantly higher number of colonies
than control (Figure 2B). Thus, reducingOvol dosage in basal cells
leads them to display enhanced proliferation potential. Interest-
ingly, whereas control andOvol1/ colonies were darkly stained
with dye, reflecting a tightly packed morphology, DKO colonies
were large, loose clusters of cells that were weakly stained (Fig-
ure 2B). We will return to this issue later.
To probe the underlying molecular defects, we compared
gene expression between control and DKO primary keratino-
cytes. Consistent with known Ovol1/OVOL2 regulation of Myc/
MYC (Nair et al., 2006; Wells et al., 2009), gene set enrichment
analysis (GSEA) (Mootha et al., 2003) of microarray data revealed
an enrichment of a MYC-activated gene set (Zeller et al., 2003) in
DKO cells compared to control cells (Figure S2A). Interestingly,
DKO cells also displayed an enrichment of three ‘‘stemness’’
gene sets (Figure S2B). MYC target and ‘‘stemness’’ gene sets
were still enriched when proliferation/cell-cycle genes were
removed from the analysis (Figures S2C and S2D), indicating
Figure 1. Loss ofOvol1 andOvol2Results in
Defective Epidermal and HF Maturation
(A) Indirect immunofluorescence of Ovol2. Gray
and yellow arrows point to basal and suprabasal
cells, respectively. White arrows point to anterior
HF cells, arrowhead points to presumptive ORS
cells, and white asterisk (*) indicates nonspecific
signals.
(B) Semiquantitative RT-PCR analysis of Ovol2
mRNA at the indicated stages of development.
Actb serves as a loading control.
(C) Hematoxylin and eosin staining (H&E).
(D–F) Indirect immunofluorescence of the indi-
cated markers. Arrows in (C) and (F) point to the
periderm. Arrowhead in (F) indicates suprabasal
cells that are K15 positive. DAPI stains the nuclei.
(G) EM images of granular and cornified layers.
Note that keratohyalin granules (red arrows) in
DKO display a rounder, less-mature morphology.
(H) Results of dye penetration assays.
(I) Morphology of HFs at E18.5.
(J) HF length (n R 2 and n R 4 per genotype for
E16.5 and E18.5, respectively). *p = 0.01; **p <
0.02; ***p < 0.004.
(K) Percentage of HFs that are AE13 positive in
E18.5 skin (nR 4 per genotype). Genotypes are as
indicated in (J). *p < 0.0001; **p < 0.02.
Error bars represent SE. Scale bars represent
25 mm (A), 50 mm (C–F and I), and 2 mm (G).
See also Figure S1.
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Among the enriched ‘‘stemness’’ genes was Trp63 (p63), which
encodes a self-renewal factor previously shown to be a master
regulator of epidermal morphogenesis (Mills et al., 1999; Yang
et al., 1999). RT-PCR confirmed elevated expression of DNp63
(Figure S2E). Moreover, whereas nuclear p63 is normally res-
tricted to the basal layer, it was detected not only strongly in basal
but also in many suprabasal cells in DKO epidermis (Figure 2C).
Sequence analysis revealed five putative Ovol binding sites in
DNp63 promoter (Figure 2D). In chromatin immunoprecipitation
(ChIP) assays, Ovol2 bound to both DNp63 and Myc promoters
in primary keratinocytes at the predicted sites (Figure 2D). Thus,
in addition toMyc, DNp63 is likely a direct target of Ovol2.
GSEA also revealed enrichment in DKO cells of gene sets
previously shown to be enriched in adult HF bulge stem cellsDevelopmental Cell 29, 47(HF-SCs) (Lien et al., 2011) (Figure S2F).
Remarkably, approximately one-quarter
(24%) of the HF-SC signature was
affectedbyOvol1/Ovol2 loss (FigureS2G).
An enrichment of a basal cell carcinoma
gene set was also observed (Figure S2H).
Among the enriched HF-SC genes were
those encoding K15 and Tcf3, which
normally are also expressed in embryonic
epidermal basal cells (Nguyen et al.,
2006; Romano et al., 2010). We observed
ectopic K15-positive cells, especially at
early embryonic stages, and a persistent
presence of Tcf3 in suprabasal cells in
DKO epidermis (Figures 1F and 2E; datanot shown). In contrast, the expression of several HF-specific/en-
richedSCmarkers, includingLrig1, Sox9,Nfatc1, andCD34 (Woo
andOro,2011), didnotexhibit anydifferencebetweencontrol and
DKO skin (Figure S3; data not shown). Collectively, these data
suggest that loss of Ovol1/Ovol2 results in an enhancement of
molecular features associated with a primitive epidermal progen-
itor cell state that overlaps but is distinct from a HF-SC state.
Epithelially Directed Ovol2 Overexpression Results in
Compromised Progenitor Cell Compartments and
Premature Differentiation in Developing Skin and
Adult HFs
To substantiate Ovol function in epidermal progenitor cells,
we generated TRE-Ovol2/K5-tTA bitransgenic (BT) mice. In the
absence of doxycycline (Dox), these mice overexpress Ovol2–58, April 14, 2014 ª2014 Elsevier Inc. 49
Figure 2. Increased Proliferation and Clo-
nogenicity with Loss of Ovol1 and Ovol2
(A) Basal cell proliferation. Shown are results of
quantification of pH3+cells in skin of the indicated
genotypes (n R 5 per genotype). *p < 0.08; **p <
0.0002.
(B) Morphology (top) and number (bottom) of col-
onies produced by keratinocytes from embryonic
skin (nR 4 per genotype). Arrow points to a DKO
colony with dense morphology at the center
reminiscent of that in a typical epithelial colony,
surrounded by loose, lightly stained peripheral
cells. *p < 0.01; **p < 0.0002.
(C) Immunofluorescent detection of p63. Top
panels are merged images showing p63 and K14
double staining. Bottom panels show p63 staining
only. Arrows point to p63-positive suprabasal cells
in DKO epidermis.
(D) ChIP analysis of Ovol2 on Myc and DNp63
(diagrams shown at the top). Triangles indicate
putative Ovol sites, with validated binding sites
shown in red. Gapdh serves as a negative control.
(E) Immunohistochemical detection of Tcf3.
Dashed line indicates the basement membrane.
Arrow indicates aberrant suprabasal Tcf3+ cells
(with their number quantified as shown at the
bottom; n = 4 per genotype). *p = 0.03.
Error bars represent SE. Scale bars represent
50 mm (C and E).
See also Figures S2 and S3.
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basal layer and the presumptive outer root sheath (ORS) of
HFs (Byrne et al., 1994; Diamond et al., 2000) (Figure S4A).
Because Ovol1 and Ovol2 recognize nearly identical DNA se-
quences (Wells et al., 2009), we expect Ovol2 overexpression
to misregulate both Ovol1 and Ovol2 targets. BT animals fed
on a Dox-free diet displayed a thinner epidermis than their
control littermates (Figure 3A) and died shortly after birth. K15
expression was nearly absent (Figure 3B), and the K1-positive
spinous compartment was reduced in size (Figures 3A and
3C). Granular layers and stratum corneum were also smaller
but these defects were less remarkable (Figures 3A and 3D;
data not shown). Microarray analysis of control and BT
embryonic skin revealed a significant downregulation of ‘‘stem-
ness’’ gene sets in the latter (Figure S4B). Furthermore, BT
embryonic skin produced dramatically decreased staining for
p63 protein (Figure 3E). These alterations suggest reduced
epidermal stem/progenitor cells upon Ovol2 overexpression.50 Developmental Cell 29, 47–58, April 14, 2014 ª2014 Elsevier Inc.HF morphogenesis was affected in a
similar manner. The number of HFs in
BT embryos was greatly reduced, and
the few residual HFs contained shorter
trunks, where presumptive HF stem/pro-
genitor cells likely reside (Nowak et al.,
2008) (Figures 3A, 3B, and 3F). In
contrast, the bulbs of the residual HFs
appeared largely normal, and expressed
proper lineage differentiation markers
including AE13, inner root sheath marker
Gata3, and matrix/precortex marker Lef1(Figures 3F and S4C). Thus, aberrantly elevated Ovol2 expres-
sion in embryonic HF epithelial cells diminishes the progenitor
cell compartment, while still permitting terminal differentiation.
The molecular similarity between embryonic epidermal pro-
genitor cells and adult HF-SCs (Blanpain and Fuchs, 2009)
prompted us to determine whether Ovol2 overexpression affects
the latter. To activate transgene expression only in adult skin
(specifically in HF ORS/bulge and epidermal basal cells), BT
mice were fed a Dox-containing diet during gestation, and Dox
was then removed postnatally at different ages (Figure S4D).
Upon Ovol2 overexpression, adult BT mice displayed a loss of
K15-positive cells in both epidermis and HF bulge (Figure 4A).
Furthermore, BT HFs displayed reduced expression of Tcf3 in
the bulge and secondary hair germ (HG) (Figure 4B). In contrast,
CD34 expression was not affected (Figure S4E). Prolonged
transgene expression resulted in hair loss in older BT mice (Fig-
ure 4C), and histological analysis confirmed a near-complete
absence of HFs; the epidermis was thickened, and the residual
Figure 3. Skin Phenotypes of Ovol2 BT Embryos
(A) H&E.
(B–D and F) Indirect immunofluorescence of the indicated markers. Slides
were double stained for K14, and nuclei were visualized by DAPI.
(E) Immunohistochemistry using a pan-p63 antibody.
Note the presence of AE13-positive cells (arrows in F) in a residual BT HF.
Gata3 staining images are shown as insets in (F). Scale bars represent
50 mm.
See also Figure S4.
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(Figure 4D; data not shown).
Adult HFs undergo cyclic bouts of growth (anagen), regression
(catagen), and resting (telogen) (Beck and Blanpain, 2012). Pro-
liferation and differentiation of stem/progenitor cells in the bulge/
HG drive telogen-to-anagen transition. To examine Ovol2 func-
tion in this transition, we activated the Ovol2 transgene at post-
natal day 49 (P49), when HFs are normally in the second telogen.
At P63, whenHFs in wild-type (WT)micewere still in telogen, HFs
in BT littermates had progressed to late anagen (Figure 4E). This
was not due to chronic effects of leaky transgene expression
(Figure S4F). Collectively, our analyses demonstrate that upon
Ovol2 overexpression, adult HFs fail to maintain stem/progenitor
cells and undergo precocious differentiation.DOvol1/Ovol2-Deficient Keratinocytes Exhibit EMT-like
Changes Ex Vivo
Our studies above highlight a positive role of Ovol1/Ovol2 in
epidermal differentiation. To seek additional and alternative
mechanisms beyond direct repression of Myc and DNp63, we
returned to the comparative expression analysis of control and
DKO keratinocytes. Remarkably, the expression of a myriad of
mesenchymal markers such as Vim (vimentin [Vim]) (153),
Acta2 (smooth muscle actin [SMA]) (103), Vcan (versican) (53),
Cdh2 (N-cadherin [Ncad]) (43), and Fn1 (fibronectin) (33) was
significantly elevated, whereas that of epithelial markers such
as Ocln (occludin) (183), Krt19 (K19) (93), and Cdh1 (Ecad)
(33) was significantly reduced in DKO cells (Table S1). RT-
PCR confirmed some of these changes (Figure 5A). Moreover,
abundant Vim-positive cells, many of which also stained positive
for K14, were detected in DKO culture (Figure 5B). The expres-
sion of genes encoding EMT-promoting transcription factors,
namely Zeb1 (433), Zeb2 (63), and Snai2 (Slug) (1.73), but not
Twist1 and Snai1, was dramatically upregulated in DKO cells
(Table S1; Figure 5A).
Consistent with EMT-like molecular changes, DKO kerati-
nocytes displayed a tendency to grow as dispersed cells and
adopted a fibroblast-like morphology (Figures 2B and 5C). Gen-
otyping revealed near-complete recombination of the floxed
Ovol2 locus (Figure S5A), indicating that these cells were of an
epithelial origin. Moreover, DKO cells were significantly more
migratory in scratch assays than control (Figure 5D).
Unrestricted epithelial plasticity/EMT may cell autonomously
compromise the differentiation potential of epidermal cells.
Indeed, Ca2+ induced less remarkable differentiation of DKO
cells compared to control (Figures 5E and 5F). Even in low-
Ca2+ medium, where control keratinocytes expressed low
but appreciable levels of mRNAs of differentiation genes
such as members of the transglutaminase (Tgm), late corni-
fied envelope (Lce), and small proline-rich protein (Sprr) fam-
ilies, DKO cells showed significantly reduced expression of
these genes (Table S2). Thus, loss of Ovol1/Ovol2 renders
keratinocytes intrinsically refractory to Ca2+-induced terminal
differentiation.
EMT-like Gene Expression and Abnormal Cell Adhesion
in Ovol1/Ovol2-Deficient Epidermis
To determine whether EMT-like changes occur in vivo, we
performed quantitative western blot analysis of freshly isolated
embryonic epidermis. The most dramatic elevation was seen
for Zeb1, Vim, and SMA, whereas a slight increase was seen
for Ncad (Figure 6A). Although only a few scattered Zeb1-posi-
tive cells were present at the basal-suprabasal junction of control
epidermis, DKO epidermis exhibited an abundant presence of
such cells in both basal and suprabasal compartments (Fig-
ure 6B). Moreover, whereas occasional Vim-positive cells were
detected in the control basal layer, almost all DKO basal cells
stained positive for Vim, albeit at a lower intensity compared to
the underlying dermis (Figure 6C). The level of Vim and Zeb1
mRNAs was also significantly increased (Figure 6D), suggesting
that their upregulation occurs at a transcriptional level. Intrigu-
ingly, the mRNA level and staining pattern of Ecad, a well-
known Zeb1 target (Peinado et al., 2007), were unaltered in
DKO epidermis (Figures 6A and S5B).evelopmental Cell 29, 47–58, April 14, 2014 ª2014 Elsevier Inc. 51
Figure 4. HF Phenotypes of Adult Ovol2 BT
Mice
(A and B) Reduced presence of K15 (A) and Tcf3
(B) proteins in BT skin. Arrow in (B) indicates a
Tcf3-positive secondary HG cell.
(C and D) Long-term overexpression of Ovol2 re-
sults in loss of hairs (C) and HFs (D). Arrow in (D)
indicates the presence of epidermal-like materials
in a residual HF.
(E) Precocious progression of BT HFs to anagen.
P_; P_ indicates the ages at which BT mice were
induced with Dox and taken for analysis. Scale
bars represent 50 mm (A, B, and D) and 20 mm (E).
See also Figure S4.
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we returned to EM analysis. Importantly, whereas basal and
spinous cells in DKO epidermis were able to form intermittent
intercellular bridges/filopodia-like structures and normal-looking
desmosomal junctions, they failed to properly ‘‘zip’’ together the
intervening membranes to maintain full adhesion to one another
(Figure 6E). These defects are strikingly similar to mice deficient
in a-catenin, which is required for actin cytoskeleton organiza-
tion to seal adjacent cell membranes during the formation of
stable epidermal cell-cell contacts (Vasioukhin et al., 2000).
Consistent with this parallel, the level of a-catenin protein was
significantly reduced in DKO epidermis (Figure 6A).
The retention of Ecad in DKO cells in vivo led us to wonder
whether artificially enhancing cell-cell contacts in cultured
DKO keratinocytes might suppress their EMT-like changes. To
address this, we added Ca2+, which induces intercellular adhe-
sion prior to differentiation (Jamora and Fuchs, 2002), to kerati-
nocyte cultures. Consequently, DKO cells no longer exhibited
as significant a deviation from the control in their expression of
most EMT-related genes, such as Cdh2, Acta2, and Snai2
(Table S1). However, the top-affected genes in low Ca2+, such
as Zeb1 and Vim, still showed increased expression in DKO
cells, albeit to a lesser extent. Importantly, Ctnna1 (a-catenin)
expression was significantly lower in Ca2+-treated DKO cells
than control. From these findings, we surmise that (1) the pres-
ence of rigid cell-cell organization and differentiation cues in vivo
might counterbalance the EMT tendency of Ovol1/Ovol2-defi-
cient epidermal cells, and (2) misregulation of Zeb1, Vim, and
Ctnna1 likely represents primary molecular effects of Ovol1/
Ovol2 loss, whereas the additional changes that occur only in
culture (e.g., reduced Cdh1 expression) may be secondary.
Zeb1 Mediates Ovol Regulation of Ctnna1, EMT, and
Terminal Differentiation
We next tested the possibility that Ovol directly regulates EMT-
inducing genes in epidermis. Regulatory regions of Zeb1, Vim,
and Snai2 genes contain Ovol binding motifs, and ChIP experi-52 Developmental Cell 29, 47–58, April 14, 2014 ª2014 Elsevier Inc.ments revealed Ovol2 binding to the
predicted sites in primary keratinocytes
(Figure 7A; data not shown). Moreover,
the relative binding strength positively
correlated with the extent of upregula-
tion in mRNA expression (see above),
with Zeb1 being the most strongly boundand most significantly upregulated. We therefore asked whether
depletion of Zeb1 rescues the defects of DKO keratinocytes.
Transfection of a Zeb1-specific small interfering RNA (siRNA),
but not a negative control siRNA, intoDKOkeratinocytes cultured
in low Ca2+ resulted in efficient Zeb1 knockdown (Figure S6A),
formation of colonies with epithelial morphology (Figure 7B),
and correction of Fn1, Cdh2, and Cdh1 mRNA expression
to near-control levels (Figure 7C). Importantly, Ctnna1 mRNA
expression was also restored after Zeb1 knockdown (Figure 7C).
The inverse correlation between Zeb1 and Ctnna1 expression
led us to examine whether Ctnna1 is a target of Zeb1 transcrip-
tional repression. Previous ChIP-sequencing (ChIP-seq) studies
(University of California at Santa Cruz genome browser) revealed
the presence of ZEB1 peaks on the human CTNNA1 promoter
(Figure S6B). Our ChIP experiments revealed Zeb1 binding to
themouseCtnna1 promoter in primary keratinocytes (Figure 7D).
In reporter assays, cotransfection with a Zeb1 expression
construct repressed luciferase activity driven by the Ctnna1 pro-
moter, but not a mutant promoter where the upstream binding
site was mutated (Figure 7E). These data establish Ctnna1 as a
direct target of Zeb1.
Next, we asked whether Zeb1 depletion affects how Ovol1/
Ovol2 deletion impacts cell adhesion and actin dynamics of
cultured DKO keratinocytes. Shortly after plating, a-catenin pro-
tein was concentrated to the cell borders of control cells that
came into close proximity of each other; over several days, the
cells eventually sealed together with a-catenin staining remain-
ing strongest at the borders (Figure 7F, left). As expected
(Vasioukhin et al., 2000), phalloidin staining revealed actin fila-
ments that localized radially at the periphery of control cells:
weak right after plating but enhanced over culturing (Figure 7F,
left). In contrast, DKO cells did not show appreciable localization
of a-catenin to the cell borders even when they were contacting
each other, and abundant stress fibers formed in these cells over
time (Figure 7F, middle). When Zeb1 was depleted, a-catenin
localization and actin cytoskeletal staining in DKO keratinocytes
resembled control cells (Figure 7F, right). No apparent effect was
Figure 5. DKO Epidermal Keratinocytes
Undergo EMT-like Molecular and Morpho-
logical Changes
(A) Semiquantitative RT-PCR. Gapdh serves as a
loading control.
(B) Increased Vim protein expression in DKO ker-
atinocytes. Shown are merged images with K14
staining.
(C) Morphology of DKO keratinocytes in high-
density culture.
(D) Scratch assay. Dashed lines indicate where the
scratches were made.
(E) Morphology of Ca2+-treated WT and DKO
keratinocytes.
(F) Indirect immunofluorescence of late epidermal
differentiation marker transglutaminase 3 (Tgm3)
in Ca2+-treated keratinocytes. DAPI stains the
nuclei. Arrows in (E) and (F) denote a large,
flat differentiated cell and Tgm3-positive cells,
respectively.
Scale bars represent 50 mm (B–F). See also
Figure S5.
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not shown).
Thus, reducing Zeb1 expression is capable to return Ovol1/
Ovol2 DKO keratinocytes to an epithelial state. Is this sufficient
to restore their differentiation potential? Indeed, Zeb1 depletion
in DKO keratinocytes led to increased mRNA levels of late
epidermal differentiation genes Tgm1 and Sprr2j (Figure 7C),
as well as partially rescued the expression of differentiation
markers Tgm3 and filaggrin (Figure S6C). In contrast, the expres-
sion of self-renewal/proliferation genes Myc, Tcf3, Krt15 (K15),
and Itga6 (a6 integrin) was not affected (Figure S6D). Interest-
ingly, Zeb1 knockdown resulted in an increased number of col-
onies formed by DKO keratinocytes while exerting a minimal
effect on control cells (Figure 7G). Collectively, our data suggest
a model in which Ovol proteins maintain the epithelial identity
and differentiation competence of epidermal progenitor cells in
part via an Ovol-Zeb1-a-catenin regulatory pathway.
DISCUSSION
Our work underscores Ovol1 and Ovol2 as critically important
regulators of epidermal morphogenesis. Overall, they pro-Developmental Cell 29, 47mote terminal differentiation within both
epidermal and HF lineages, as well as
restrict molecular stem/progenitor cell
traits and proliferation potential. Impor-
tantly, the study uncovers a previously
unrecognized mechanism, where molec-
ular machinery used to regulate epithelial
plasticity confers differentiation compe-
tence to epidermal progenitor cells.
Although K14-Cre-mediated deletion
of Ovol2 results in a near-complete arrest
of mammary morphogenesis (Watanabe
et al., 2014, this issue of Developmental
Cell), it severely impacts epidermal differ-
entiation only when Ovol1 is also deleted(this work). In various assays, Ovol1/ skin either displayed
a status that is intermediate between control and DKO or was
similar to control, whereas Ovol2 SSKO skin was indistinguish-
able from the control (Figures 1, S1, 2, and S2; data not shown).
Ovol1 and Ovol2 are expressed in distinct but overlapping sites
of the developing epidermis. It is possible that under physiolog-
ical conditions, they each regulate the behavior of distinct
subpopulations of epidermal progenitor cells. However, when
one is absent, the other is upregulated, reflecting compensatory
attempts of the cells to ensure that essential developmental/
cellular processes can take place. Proper epidermal differentia-
tion leading to barrier formation is essential for the organism’s
extrautero survival. Perhaps for this reason, functional compen-
sation/redundancy between Ovol1 and Ovol2 is particularly
important in developing epidermal progenitor cells.
Interestingly, both reduction and increase in Ovol dosage lead
to catastrophic consequences, although for different underlying
reasons. For example, DKO embryos produce HFs that contain
few AE13-positive cells, whereas BT HFs, when formed, seem
to generate AE13-positive cells at the expense of HF progenitor
cells. These findings imply the need to exquisitely control total
Ovol protein levels in skin in order to balance progenitor cell–58, April 14, 2014 ª2014 Elsevier Inc. 53
Figure 6. In Vivo EMT-Related Changes in DKO Epidermis
(A) Western blotting analysis of isolated epidermis. Gapdh serves as a loading control. Positions of molecular weight markers are indicated on the right.
(B) Immunofluorescent detection of Zeb1 (top), with quantification of Zeb1-positive cells shown at the bottom (n = 3 per genotype; *p < 0.001). Middle panels are
merged images showing Zeb1 and K14 double staining. Note that many cells in the expanded K14-positive zone in DKO skin express Zeb1.
(C) Immunofluorescent detection of Vim. Single-channel (top) and merged (bottom, with K14) images are shown, with high-magnification images included as
insets.
(D) RT-qPCR analysis of Vim and Zeb1 mRNAs in epidermis isolated from control and DKO skin. *p = 0.109; **p = 0.096.
(E) EM images showing control and DKO basal (top) and spinous (bottom) cells. Red arrows point to intercellular bridges, red arrowheads point to desmosomes,
red stars indicate intercellular gaps, and white arrows point to hemidesmosomes.
Error bars represent SE. Scale bars represent 50 mm (B and C), 5.5 mm (upper panels of E), and 1 mm (lower panels of E).
See also Figure S5.
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moters contain Ovol binding motifs, and Ovol1 autorepresses
(Nair et al., 2007; Teng et al., 2007;Wells et al., 2009). These find-54 Developmental Cell 29, 47–58, April 14, 2014 ª2014 Elsevier Inc.ings suggest that Ovol1 and Ovol2 may mutually repress each
other’s expression (and autorepress) to maintain adequate total
levels of Ovol proteins.
Figure 7. Evidence for an Ovol-Zeb1-
a-Catenin Pathway and Zeb1 Importance
in Ovol1/Ovol2 DKO Phenotypes
(A) ChIP analysis of Ovol2 on Zeb1, Vim, and Snai2
(see legend to Figure 2D for more details).
(B) Morphology (top) and type (bottom) of colonies
produced by DKO keratinocytes treated with
control (Neg) or Zeb1 siRNA. **p < 0.0002.
(C) RT-qPCR analysis of Neg or Zeb1 siRNA-
treated keratinocytes. Gapdh expression was
used for normalization.
(D) ChIP revealing Zeb1 binding to Ctnna1 pro-
moter at predicted sites. The Gapdh promoter
serves as a negative control.
(E) WT but not mutated Ctnna1 promoter is
repressed by Zeb1 in luciferase reporter assays.
(F) Indirect immunofluorescence of a-catenin and
phalloidin on keratinocytes treated with Neg or
Zeb1 siRNA at the indicated time points. Top and
middle panels are merged images for a-catenin
and DAPI. Bottom panels are merged images for
phalloidin and DAPI.
(G) Effect of Zeb1 knockdown on keratinocyte
clonogenicity. Graph depicts fold difference in the
number of colonies comparing Neg control siRNA
to Zeb1 siRNA.
Error bars represent SE. Scale bars represent
50 mm (B and F).
See also Figure S6.
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and multipotent adult HF-SCs display sensitivity to Ovol dosage
by altering their gene expression and differentiation programs.
Thus, this work adds Ovol1/Ovol2 to the short list of transcription
factors including Tcf3, Lhx2, Sox9, and Nfatc1 that regulate the
behavior of adult HF-SCs. Interestingly, adult Ovol2 SSKO mice
show a slight delay in anagen entry with incomplete penetrance
(data not shown), mirroring the premature progression to anagen
observed in Ovol2 BT mice. Further evidence that Ovol proteins
are stem/progenitor cell-limiting factors to facilitate differentia-
tion of adult HF-SCs awaits the generation of appropriate skin-
specificOvol1/Ovol2-deficient mouse models that do not exhibit
perinatal lethality.
Our work mechanistically connects terminal differentiation,
EMT, and cell adhesion of epidermal progenitor cells via
an Ovol-Zeb1-a-catenin sequential-repression pathway. DKO
epidermal cells share the a-catenin deficiency-induced defects
in actin cytoskeletal organization and intercellular adhesionDevelopmental Cell 29, 47(Vasioukhin et al., 2001). Furthermore,
like skin-specific Ctnna1 knockout, DKO
mice show hyperproliferative epidermis
and defective HF development. That
Ovol regulation of a-catenin is mediated
by Zeb1 is particularly interesting.
Although Cdh1 has been extensively
studied as a Zeb1 target in cancer cells
(Peinado et al., 2007), our data show-
case a-catenin as the primary effector
downstream of Ovol and Zeb1 during
epidermal morphogenesis. This function
of mammalian Ovol, namely regulatingactin cytoskeleton, is somewhat reminiscent of the role of
DrosophilaOvo (Delon et al., 2003) but with an interestingmolec-
ular twist.
It is intriguing to ponder why an inducer of nonepithelial fate is
built into the molecular circuit that promotes epithelial adhesion
and differentiation. Dynamic changes associated with the adhe-
rens junctions provide flexible intercellular adhesions, with tran-
sient breakage and reestablishment of adhesive forces likely
underlying the proliferative events within the epidermal stem/
progenitor cell compartments and themigration of differentiating
cells from basal to suprabasal locations (Kobielak and Fuchs,
2004; Watt, 1987). Our study demonstrates that this extremely
mild form of epithelial plasticity during epidermal development
shares some common molecular features and regulators, such
as Ovol and Zeb1, with its more ‘‘radical’’ cousins: EMT and
mesenchymal-to-epithelial transition (MET) (Ocan˜a and Nieto,
2008; Roca et al., 2013).Moreover, Ovol repression of a plasticity
inducer (Zeb1) that suppresses epithelial adhesion (a-catenin)–58, April 14, 2014 ª2014 Elsevier Inc. 55
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ance between adhesion relaxation and reestablishment. Sup-
porting the broad relevance of this regulation, a spontaneous
noncoding point mutation (Twirler) in the first intron of Zeb1
that disrupts a conserved base pair within the +286 Ovol1/
Ovol2 binding consensus (Figure 7A) results in inner ear defects
(Kurima et al., 2011). Our findings raise the possibility that Zeb1
may normally function in developing epidermis as an adhesion
relaxer. The presence of Zeb1 protein at the basal-suprabasal
junction is consistent with this notion. Although examination of
Zeb1 null embryonic epidermis did not reveal any apparent
anomaly (data not shown), it remains possible that Zeb2 pro-
vides functional compensation.
EMT has recently been shown to promote stem cell properties
(Chaffer et al., 2013; Guo et al., 2012; Mani et al., 2008). The fact
that Ovol1/Ovol2-deficient epidermal cells are EMT prone and
‘‘locked’’ in a proliferative progenitor state seems consistent
with this. However, inhibition of EMT by Zeb1 knockdown in
Ovol1/Ovol2 DKO keratinocytes does not decrease but, instead,
increases colony formation. Thus, an epithelial fate is required for
maximal clonogenicity, a surrogate measure of stem/progenitor
activity of epidermal cells. Ovol1/Ovol2 may also suppress
proliferation potential via additional mechanisms independent
of Zeb1, a-catenin, or EMT-like events, such as via regulating
Myc and p63. Regardless, our research of Ovol involvement in
suppressing both progenitor-like traits and epithelial plasticity




K14-Cre mice, K5-tTA mice, floxed (f) and null () alleles of Ovol2 have
been described previously by Andl et al. (2004), Diamond et al. (2000), and
Unezaki et al. (2007), respectively. TRE-Ovol2-Flag transgenic founders
were generated by pronuclei injection of CB6F1 mouse eggs at the University
of California, Irvine (UCI) TransgenicMouse Facility. All experiments have been
approved by, and conform to the regulatory guidelines of, the UCI International
Animal Care and Use Committee.
Immunostaining
For indirect immunofluorescence, mouse back skins were freshly frozen in op-
timum cutting temperature (OCT) compound (Tissue-Tek) and stained using
the appropriate antibodies. The number of pH3+ cells was counted in at least
three fields (using ImageJ of skin sections at 103 magnification) per mouse.
Immunohistochemical detection of p63 and Tcf3 was performed with parafor-
maldehyde-fixed paraffin-embedded sections, using Vector ABC (Vector
Laboratories; PK-6100) and diaminobenzidine (DAB) (DAKO; K3468) kits per
manufacturer’s instructions.
Isolation of Epidermis and Culturing of Primary Keratinocytes
Skins of E18.5 embryos were placed with the dermis facing down in Petri
dishes with 1 ml of 5 mg/ml dispase (STEMCELL Technologies; 7913) and
1 ml CnT-07 media (CELLnTEC; CnT-07). Skins were incubated in the dis-
pase/media solution at room temperature for 2–4 hr or overnight at 4C. After
incubation, the dermis and epidermis are separated with forceps.
Keratinocytes were isolated from the E18.5 skin of WT and mutant litter-
mates using an established protocol (CELLnTEC). About 2–4 3 106 cells
were recovered from each mouse and were plated at comparable cell den-
sities among genotypes. The cells were cultured in CnT-02 media (CELLnTEC)
with or without addition of 1.2 mM Ca2+ for 3–5 days prior to experiments. For
clonogenicity assay, cells were plated at 1,000 cells/cm2 and allowed to grow
for 2 weeks, followed by staining with 0.5% methylene blue and 50% ethanol56 Developmental Cell 29, 47–58, April 14, 2014 ª2014 Elsevier Inc.for 30 min. For quantitative analysis, two wells of a 6-well plate were counted
and averaged per mouse.
ChIP Assay
ChIP was performed according to the protocol described previously by Dahl
and Collas (2008) using primary keratinocytes isolated from newborn control
embryos and cultured to reach 70%–80% confluency.
Microarray Analysis
Hybridization of arrays (GeneChip Mouse Exon 1.0 ST Array; Affymetrix) was
performed in duplicate using independent biological samples. Affymetrix
GeneChip Analysis Suite software (MAS 5.0) was used to generate raw data,
and genes with normalized expression levels over detection threshold were
called and analyzed for differential expression using the Cyber T program
(Long et al., 2001) (http://cybert.ics.uci.edu/).
siRNA Knockdown
Primary mouse keratinocytes were reverse transfected in 6-well plates using
Lipofectamine RNAiMAX Transfection Reagent (Life Technologies; 13778-
075) according to the manufacturer’s recommendations. The following
Silencer predesigned siRNAs (Life Technologies) were used at a concentration
of 10–25 nM: Silencer Select Negative Control No. 1 siRNA (4390843), and
Zeb1 Silencer Select siRNA (4390771). Cells were harvested 24–96 hr after
transfection for RNA analysis or up to 2 weeks for morphological analysis.
Additional details for the above procedures, as well as procedures for his-
tology, laser-capture microdissection, RT-PCR, barrier, scratch, and reporter
assays, western blotting, GSEA, and statistical analysis, are described in the
Supplemental Experimental Procedures.
ACCESSION NUMBERS
The microarray data have been deposited into the GEO database (accession
number GSE55075).
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six figures, and two tables and can be found with this article online at http://
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